Trial intelligence / Profile preview

Probiotics for Prevention of Premature Birth in Women with Bacterial Vaginosis

NCT00303082Phase 3Terminated

Sponsor
Fundação Oswaldo Cruz
Start
Jan 2006
Primary completion
Jan 2009
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of lactobacillus rhamnosus gr-1 in preterm birth, sponsored by Fundação Oswaldo Cruz. Started Jan 2006; status: terminated.

02

Drugs

lactobacillus rhamnosus gr-1
03

Conditions

preterm birth

Beyond the preview

Go deeper on NCT00303082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00303082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call